Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 11;5(6):e00257. doi: 10.1002/rcr2.257

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Chest computed tomography (CT) scans of the left upper lobe of the lung before and after initiating nivolumab. (A) No finding suggesting interstitial lung disease (ILD) before administration of nivolumab. (B) Appearance of the combination of ground‐grass nodule (GGN) and consolidation after eight cycles of nivolumab. (C) Improvement in CT findings after immunosuppressive treatment for 1 month; the GGN disappeared but the consolidation remained. (D) Re‐exacerbation of the combination of GGN and consolidation after tapering the dose of prednisolone to 30 mg daily.